ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RNLX Renalytix PLC

0.641
0.00 (0.00%)
Pre Market
Last Updated: 04:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Renalytix PLC RNLX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.641 04:00:00
Open Price Low Price High Price Close Price Prev Close
0.641
more quote information »

Recent News

Date Time Source Heading
5/08/20249:05IHNWFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
4/08/202407:00GLOBERenalytix Announces Financing with Expected Size of up to $4..
3/14/202407:00GLOBEKidneyIntelX™ included in Final KDIGO 2024 Clinical..
2/15/202407:00GLOBERenalytix Reports Financial Results for Second Quarter of..
2/15/202407:00EDGAR2Form 8-K - Current report
2/14/202416:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/09/202409:00GLOBERenalytix to Participate in the BTIG MedTech, Digital..
1/17/202407:15EDGAR2Form 8-K - Current report
1/10/202407:15EDGAR2Form 8-K - Current report
1/10/202407:00GLOBENew published data demonstrates KidneyIntelX™ has broad..
12/29/202316:02EDGAR2Form 8-K - Current report
11/17/202316:01EDGAR2Form ARS - Annual Report to Security Holders
11/14/202307:00GLOBERenalytix Reports Financial Results for First Quarter of..
11/07/202307:00GLOBERenalytix to Report Financial Results for First Quarter..
11/03/202316:04EDGAR2Form PRE 14A - Other preliminary proxy statements
10/24/202308:00EDGAR2Form 8-K - Current report
10/06/202307:00GLOBEUS Patent Office Allows Patent Claims for Intellectual..
9/28/202307:00GLOBERenalytix Reports Full Year Fiscal 2023 Results
9/25/202307:00GLOBERenalytix to Report Financial Results for Fourth Quarter and..
9/08/202316:04EDGAR2Form 8-K - Current report
9/07/202307:00GLOBERenalytix Appoints Senior Executive Howard Doran as Chief..
8/03/202307:00GLOBERenalytix Clinical Advisory Board Formed to Support..
7/21/202307:00GLOBERenalytix Announces Middle East Distribution Agreement with..
7/07/202307:00GLOBELate-Breaking KidneyIntelX Evidence Released at 83rd..
7/03/202307:00GLOBERenalytix Appoints Financial Executive Catherine Coste to..
6/29/202318:58DJNRenalytix Gets FDA De Novo Marketing Authorization for..
6/29/202318:01GLOBEFDA Grants De Novo Marketing Authorization for..
6/15/202307:00GLOBEKidneyIntelX™ Clinical Decision Impact / Validation and..
6/09/202307:00GLOBERenalytix Reports Financial Results for Third Quarter of..
6/05/202307:00GLOBERenalytix to Report Third Quarter Fiscal Year 2023 Financial..
5/25/202307:00GLOBERenalytix selects EVERSANA® to expand commercialization of..

Your Recent History

Delayed Upgrade Clock